Outcomes of transoral laser microsurgical management of T_1bstage glottic cancer

Abstract

Transoral laser microsurgery yields relatively high rates of oncological control and acceptable voice outcomes, and thus shows utility as a primary treatment modality for T1b glottic cancer.

Voice outcomes after transoral laser surgery for T1b squamous cell carcinoma of the glottis: Our experience in 20 patients over 12 years

“…A literature search has identified only four studies which specifically analysed voice outcomes of T1b cancer patients treated with TLM. Lombardo et al had 30, Song et al 21, Lee et al 7 and Taylor et al in a multicentre Canadian study had 21 in their studies 3,4,7,8 . This demonstrates the scarcity of our knowledge in this specific patient group.…”

“…Evidence demonstrates that TLM offers oncological outcomes which are at least equivalent to those offered with RT. 7,8 Gioacchani et al 9 demonstrated this further in a systematic review specifically considering T1b cancers.…”

“…Lombardo et al had 30, Song et al 21, Lee et al 7 and Taylor et al in a multicentre Canadian study had 21 in their studies. 3,4,7,8 This demonstrates the scarcity of our knowledge in this specific patient group.…”

Outcomes of frontolateral vertical partial laryngectomy in T1b glottic carcinomas

“…Therefore, in these cases, even if it causes poorer functional results, it is recommended to resect the corresponding cartilaginous framework, to achieve a tumor free margin, and thus reduce the recurrence rate [10]. Table 3 compares the present study, which uses FVPL to studies employing various methods for the treatment of T1b glottic cancer published between 1997 and 2018 [10,[16][17][18][19][20][21].…”

Voice in T1b glottic tumours, intratympanic steroids for salvage in sensorineural hearing loss, intranasal steroids for obstructive sleep apnoea and a new procedure for post-radiation nasal stenosis

“…In a useful paper with substantial long-term results, Song et al . evaluated the oncological and voice outcomes of transoral laser microsurgery for T 1b glottic cancer patients 7 . The study revealed relatively high rates of oncological control and acceptable voice outcomes, showing its utility as a primary treatment modality for T 1b glottic cancer.…”